Attached files
file | filename |
---|---|
EX-32.1 - EXHIBIT 32.1 - Zomedica Corp. | exh_321.htm |
EX-31.1 - EXHIBIT 31.1 - Zomedica Corp. | exh_311.htm |
EX-10.33 - EXHIBIT 10.33 - Zomedica Corp. | exh_1033.htm |
EX-10.32 - EXHIBIT 10.32 - Zomedica Corp. | exh_1032.htm |
EX-10.31 - EXHIBIT 10.31 - Zomedica Corp. | exh_1031.htm |
EX-4.1 - EXHIBIT 4.1 - Zomedica Corp. | exh_41.htm |
10-K - FORM 10-K - Zomedica Corp. | f10k_022620p.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statement No(s). 333-228926 and 333-229014 on Form S-3 and Registration Statement No(s). 333-229343, 333-223893 and 333-221992 on Form S-8 of our auditors’ report dated February 26, 2020, relating to the consolidated financial statements of Zomedica Pharmaceuticals Corp. and its subsidiaries (the “Company”) for the years ended December 31, 2019 and 2018 (which expresses an unqualified opinion and includes an explanatory paragraph relating to the conditions and events that raise substantial doubt on the Company’s ability to continue as a going concern) appearing in this Report on Form 10-K dated February 26, 2020.
Chartered Professional Accountants
Licensed Public Accountants
February 26, 2020
Toronto, Canada